v3.25.3
Condensed Statements of Changes in Convertible Preferred Stock and Stockholders’ Deficit (Unaudited) - USD ($)
$ in Thousands
Total
Conversion of preferred stock to common stock upon IPO
Conversion of redeemable convertible preferred stock warrants to common stock warrants on IPO
Conversion of convertible notes to common stock upon IPO
IPO
Common Stock
Common Stock
Conversion of preferred stock to common stock upon IPO
Common Stock
Conversion of convertible notes to common stock upon IPO
Common Stock
IPO
Additional Paid-in Capital
Additional Paid-in Capital
Conversion of preferred stock to common stock upon IPO
Additional Paid-in Capital
Conversion of redeemable convertible preferred stock warrants to common stock warrants on IPO
Additional Paid-in Capital
Conversion of convertible notes to common stock upon IPO
Additional Paid-in Capital
IPO
Accumulated Other Comprehensive Income
Accumulated Deficit
Temporary equity, beginning balance at Dec. 31, 2023 $ 74,475                              
Temporary equity, ending balance at Mar. 31, 2024 74,475                              
Beginning balance (in shares) at Dec. 31, 2023           57,354                    
Beginning balance at Dec. 31, 2023 (39,737)         $ 1       $ 1,328         $ 356 $ (41,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation expense 168                 168            
Net loss (3,600)                             (3,600)
Other Comprehensive income (loss), net 42                           42  
Ending balance (in shares) at Mar. 31, 2024           57,354                    
Ending balance at Mar. 31, 2024 (43,127)         $ 1       1,496         398 (45,022)
Temporary equity, beginning balance at Dec. 31, 2023 74,475                              
Temporary equity, ending balance at Sep. 30, 2024 74,475                              
Beginning balance (in shares) at Dec. 31, 2023           57,354                    
Beginning balance at Dec. 31, 2023 (39,737)         $ 1       1,328         356 (41,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss (11,827)                              
Other Comprehensive income (loss), net 46                              
Ending balance (in shares) at Sep. 30, 2024           83,882                    
Ending balance at Sep. 30, 2024 (50,877)         $ 1       1,969         402 (53,249)
Temporary equity, beginning balance at Mar. 31, 2024 74,475                              
Temporary equity, ending balance at Jun. 30, 2024 74,475                              
Beginning balance (in shares) at Mar. 31, 2024           57,354                    
Beginning balance at Mar. 31, 2024 (43,127)         $ 1       1,496         398 (45,022)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation expense 170                 170            
Net loss (4,172)                             (4,172)
Other Comprehensive income (loss), net (57)                           (57)  
Ending balance (in shares) at Jun. 30, 2024           57,354                    
Ending balance at Jun. 30, 2024 (47,186)         $ 1       1,666         341 (49,194)
Temporary equity, ending balance at Sep. 30, 2024 74,475                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance of common stock (in shares)           26,528                    
Issuance of common stock 66                 66            
Stock-based compensation expense 237                 237            
Net loss (4,055)                             (4,055)
Other Comprehensive income (loss), net 61                           61  
Ending balance (in shares) at Sep. 30, 2024           83,882                    
Ending balance at Sep. 30, 2024 (50,877)         $ 1       1,969         402 (53,249)
Temporary equity, beginning balance at Dec. 31, 2024 74,475                              
Increase (Decrease) in Temporary Equity [Roll Forward]                                
Issuance of preferred stock in private placement, net of issuance cost 19,542                              
Exercise of preferred stock warrant 130                              
Temporary equity, ending balance at Mar. 31, 2025 $ 94,147                              
Beginning balance (in shares) at Dec. 31, 2024 83,882         83,882                    
Beginning balance at Dec. 31, 2024 $ (54,695)         $ 1       2,148         197 (57,041)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance of common stock (in shares)           18,903                    
Issuance of common stock 32                 32            
Stock-based compensation expense 127                 127            
Net loss (4,662)                             (4,662)
Other Comprehensive income (loss), net (116)                           (116)  
Ending balance (in shares) at Mar. 31, 2025           102,785                    
Ending balance at Mar. 31, 2025 (59,314)         $ 1       2,307         81 (61,703)
Temporary equity, beginning balance at Dec. 31, 2024 74,475                              
Increase (Decrease) in Temporary Equity [Roll Forward]                                
Issuance of preferred stock in private placement, net of issuance cost 40,130                              
Exercise of preferred stock warrant 455                              
Conversion of preferred stock to common stock upon IPO (115,060)                              
Temporary equity, ending balance at Sep. 30, 2025 $ 0                              
Beginning balance (in shares) at Dec. 31, 2024 83,882         83,882                    
Beginning balance at Dec. 31, 2024 $ (54,695)         $ 1       2,148         197 (57,041)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss (32,587)                              
Other Comprehensive income (loss), net $ (158)                              
Ending balance (in shares) at Sep. 30, 2025 20,584,787         20,584,787                    
Ending balance at Sep. 30, 2025 $ 147,832         $ 21       237,400         39 (89,628)
Temporary equity, beginning balance at Mar. 31, 2025 94,147                              
Increase (Decrease) in Temporary Equity [Roll Forward]                                
Issuance of preferred stock in private placement, net of issuance cost 31,903                              
Exercise of preferred stock warrant 650                              
Temporary equity, ending balance at Jun. 30, 2025 126,700                              
Beginning balance (in shares) at Mar. 31, 2025           102,785                    
Beginning balance at Mar. 31, 2025 (59,314)         $ 1       2,307         81 (61,703)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance of common stock (in shares)           46,018                    
Issuance of common stock 119                 119            
Stock-based compensation expense 190                 190            
Net loss (19,196)                             (19,196)
Other Comprehensive income (loss), net 1                           1  
Ending balance (in shares) at Jun. 30, 2025           148,803                    
Ending balance at Jun. 30, 2025 (78,200)         $ 1       2,616         82 (80,899)
Increase (Decrease) in Temporary Equity [Roll Forward]                                
Exercise of preferred stock warrant 264                              
Conversion of preferred stock to common stock upon IPO (126,964)                              
Temporary equity, ending balance at Sep. 30, 2025 0                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Conversion of convertible securities (in shares)             12,366,434 2,810,428                
Conversion of convertible securities   $ 126,964 $ 637 $ 42,156     $ 12 $ 3     $ 126,952 $ 637 $ 42,153      
Issuance of common stock (in shares)           259,122     5,000,000              
Issuance of common stock 537       $ 64,212       $ 5 537       $ 64,207    
Stock-based compensation expense 298                 298            
Net loss (8,729)                             (8,729)
Other Comprehensive income (loss), net $ (43)                           (43)  
Ending balance (in shares) at Sep. 30, 2025 20,584,787         20,584,787                    
Ending balance at Sep. 30, 2025 $ 147,832         $ 21       $ 237,400         $ 39 $ (89,628)